Management of Elevated Hematocrit in Heart Failure Patients

Clinical Approach

The American College of Cardiology recommends assessing volume status using a comprehensive approach that includes balance of fluids, blood pressure, biomarkers, bioimpedance vector analysis, and blood volume assessment, with blood pressure and biomarkers being key components 1
Blood volume assessment is a critical component of the clinical approach, as recommended by the European Society of Cardiology 2

The European Society of Cardiology recommends continuing aggressive diuretic therapy if congestion persists, regardless of rising hematocrit, with a strength of evidence level of I (high) 3
The American College of Cardiology recommends starting with IV loop diuretics at doses equal to or exceeding the chronic oral daily dose for patients already on diuretics, with a strength of evidence level of IIa (moderate) 3
Monitoring symptoms, urine output, renal function, and electrolytes regularly during IV diuretic use is crucial, as recommended by the European Heart Journal 3

The American Heart Association recommends limiting fluid intake to approximately 2 liters per day for most heart failure patients, with a strength of evidence level of IIb (weak) 6
Weight-based fluid restriction (30 mL/kg body weight, or 35 mL/kg if >85 kg) may be more reasonable than fixed restrictions, as suggested by the European Society of Cardiology 2

The American College of Cardiology recommends continuing ACE inhibitors/ARBs and beta-blockers in stable patients without hemodynamic instability, even as hematocrit rises with decongestion, with a strength of evidence level of I (high) 4
These medications should only be held if symptomatic hypotension develops, cardiogenic shock is present, or acute hemodynamic instability occurs, as recommended by the European Heart Journal 3